This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Pure Tech Lyt 100, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Simon John Hatch: Inventor in Pulmonary Fibrosis Treatment
Introduction
Simon John Hatch is an inventor based in Wayne, Pennsylvania. His patent work concerns a potential treatment approach for idiopathic pulmonary fibrosis (IPF), a progressive lung disease.
Latest Patents
Hatch is associated with one patent, 1 patent: “Methods of Treating Idiopathic Pulmonary Fibrosis with Deupirfenidone.” The disclosed method involves administering deuterium-enriched pirfenidone, known as LYT-100, at a total daily dose of about 1,650 to 2,500 milligrams to a subject in need of treatment.
Career Highlights
Hatch is associated with PureTech Lyt 100, Inc. His patent work focuses on the use of deupirfenidone in treating IPF.
Collaborations
Hatch’s listed coworkers include Liza C. Micioni and David Andrew Golod.
Conclusion
Simon John Hatch’s patent activity centers on a proposed deupirfenidone treatment method for idiopathic pulmonary fibrosis, reflecting research into potential therapeutic approaches for the disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile